Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy
 For more images, please select "images" in the filters.
A phase I study of fenretinide (LXS) Lym-X-Sorb™ oral powder in patients with recurrent or resistant neuroblastoma
Synergism via reactive oxygen species of fenretinide combined with other anti-neoplastic agents in preclinical models of recurrent neuroblastoma